Myovant Sciences Ltd. (NYSE: MYOV) started the day on January 11, 2021, with a price decrease of -6.27% at $22.28. During the day, the stock rose to $23.67 and sunk to $22.07 before settling in for the price of $23.77 at the close. Taking a more long-term approach, MYOV posted a 52-week range of $5.98-$30.90.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 17.70%. This publicly-traded company’s shares outstanding now amounts to $89.74 million, simultaneously with a float of $32.78 million. The organization now has a market capitalization sitting at $2.14 billion. At the time of writing, stock’s 50-day Moving Average stood at $21.69, while the 200-day Moving Average is $17.30.
Myovant Sciences Ltd. (MYOV) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Myovant Sciences Ltd.’s current insider ownership accounts for 0.50%, in contrast to 34.80% institutional ownership. According to the most recent insider trade that took place on Dec 28, this organization’s Principal Fin’l & Accounting sold 11,800 shares at the rate of 30.00, making the entire transaction reach 354,000 in total value, affecting insider ownership by 163,470. Preceding that transaction, on Dec 18, Company’s General Counsel & Corp. Secy. sold 10,000 for 25.41, making the whole transaction’s value amount to 254,054. This particular insider is now the holder of 145,865 in total.
Myovant Sciences Ltd. (MYOV) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2020, the organization reported -$0.75 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.73) by -$0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.84 per share during the current fiscal year.
Myovant Sciences Ltd.’s EPS increase for this current 12-month fiscal period is 17.70% and is forecasted to reach -2.47 in the upcoming year.
Myovant Sciences Ltd. (NYSE: MYOV) Trading Performance Indicators
Let’s observe the current performance indicators for Myovant Sciences Ltd. (MYOV). It’s Quick Ratio in the last reported quarter now stands at 1.80. The Stock has managed to achieve an average true range (ATR) of 2.07. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 64.21.
In the same vein, MYOV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.81, a figure that is expected to reach -0.85 in the next quarter, and analysts are predicting that it will be -2.47 at the market close of one year from today.
Technical Analysis of Myovant Sciences Ltd. (MYOV)
If we take a close look at the recent performances of Myovant Sciences Ltd. (NYSE: MYOV), its last 5-days Average volume was 1.39 million that shows plunge from its year to date volume of 1.44 million. During the previous 9 days, stock’s Stochastic %D was recorded 15.54% While, its Average True Range was 2.13.
Raw Stochastic average of Myovant Sciences Ltd. (MYOV) in the period of the previous 100 days is set at 50.69%, which indicates a major rise in contrast to 2.38% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 102.70% that was higher than 89.36% volatility it exhibited in the past 100-days period.